Abstract
Background: Hyperexcitability of N-methyl-d-aspartate (NMDA) receptors may play a role in the persistence of phantom pain. Dextromethorphan (DM) blocks NMDA receptors.
Methods: Eight cancer and two noncancer amputees with established, disabling phantom pain received oral DM 60 or 90 mg twice daily (BID) in a three-period double-blind crossover placebo-controlled trial. This followed an open-phase trial in which either dose was given three times daily if pain relief during the double-blind phase was <50% of pretreatment intensity. Patients then underwent a 3-month phase of treatment with the best regimen and a subsequent 1-month posttreatment follow-up.
Results: All patients reported a >50% decrease in pain intensity, better mood, and lower sedation in each treatment phase. Four individuals reported this level of pain relief with the 60-mg and one with the 90-mg BID regimen during the double-blind phase, whereas two amputees benefited from the 60-mg and three from the 90-mg thrice-daily regimen in the open-phase trial. One reported exacerbation of pain with the 90-mg BID regimen, and three reported pain rebound at the 1-month posttreatment follow-up phase. Three patients stopped all previous analgesic use during the study.
Conclusions: Persistent phantom pain probably involves NMDA receptor hyperexcitability because DM 120 to 270 mg/day mitigated the pain satisfactorily.
Similar content being viewed by others
REFERENCES
Devor M. The pathophysiology of damaged peripheral nerves. In: Wall PD, Melzack R, eds. Textbook of Pain. 3rd ed. London: Churchill Livingston, 1994: 79–100.
Melzack R. Phantom limb pain. Anesthesiology 1971; 35: 409–19.
Bach S, Noreng MF, Tjellden NU. Phantom limb pain in amputees during the first 12 months following limb amputation, after preoperative lumbar epidural blockade. Pain 1988; 33: 297–301.
Danshaw CB. An anesthetic approach to amputation and pain syndromes. Phys Med Rehabil Clin North Am 2000; 11: 553–7.
Nikolajsen L, Jensen TS. Phantom limb pain. Curr Rev Pain 2000; 4: 166–170.
Jensen TS, Krebs B, Nielsen J, Rasmussen P. Immediate and long-term phantom limb pain in amputees: incidence, clinical characteristics and relationship to pre-amputation pain. Pain 1985; 21: 267–78.
Woolf CJ, Wall PD. The relative effectiveness of C primary afferent fibres of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci 1986; 6: 1433–43.
Ren K, Hylden JL, Williams GM, et al. The effects of a non-competitive NMDA receptor antagonist, MK801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain 1992; 50: 331–44.
Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293–9.
Eisenberg E, Pud D. Can patients with chronic neuropathic pain be cure of dextromethorphan in pain control. Pain 1998; 74: 337–9.
Nikolajsen L, Hansen CL, Nielsen J, et al. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996; 67: 69–77.
Nikolajsen L, Gottrup H, Kristensen AG, Jensen TS. Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. Anesth Analg 2000; 91: 960–6.
Gottschalk A, Schroeder F, Ufer M, Oncu A, Buerkle H, Standl T. Amantadine, a N-methyl-D-aspartate receptor antagonist, does not enhance postoperative analgesia in women undergoing abdominal hysterectomy. Anesth Analg 2001; 93: 192–6.
Weinbroum AA, Gorodezky A, Niv D, et al. Dextromethorphan attenuation of postoperative pain and primary and secondary thermal hyperalgesia. Can J Anaesth 2001; 48: 167–74.
McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomized controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127–33.
Ilkjaer S, Dirks J, Brennum M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans. Br J Anaesth 1997; 79: 600–5.
Angrilli A, Koster U. Psychophysiological stress responses in amputees with and without phantom limb pain. Physiol Behav 2000; 68: 699–706.
Ben-Abraham R, Weinbroum AA. Dextromethorphan in chronic pain: a disappointing update. Isr Med Assoc J 2000; 2: 708–10.
Mercadante S, Casuccio A, Genovese G. Ineffectiveness of dextromethorphan in cancer pain. J Pain Symptom Manage 1998; 16: 317–22.
Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48: 1212–8.
Kauppila T, Gronroos M, Pertovaara A. An attempt to attenuate experimental pain in humans by dextromethorphan, an NMDA receptor antagonist. Pharmacol Biochem Behav 1995; 52: 641–4.
Tal M, Bennet G. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neurosci Lett 1993; 151: 107–10.
Sugimoto T, Bennett G, Kajander K. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of chronic constriction injury, transection, and strychnine. Pain 1990; 42: 205–13.
Weinbroum AA. Dextromethorphan reduces immediate and late postoperative analgesic requirements and improves patients’ subjective scorings after epidural lidocaine and general anesthesia. Anesth Analg 2002; 94: 1547–52.
Weinbroum AA, Rudick V, Paret G, Ben-Abraham R. The role of dextromethorphan in pain control. Can J Anaesth 2000; 47: 585–96.
Henderson DJ, Withington BS, Wilson JA, Morrison LM. Perioperative dextromethorphan reduces postoperative pain after hysterectomy. Anesth Analg 1999; 89: 399–402.
Suzuki T, Kato J, Saeki S, Ogawa S, Suzuki H. Analgesic effect of dextromethorphan for postherpetic neuralgia (in Japanese). Masui 1996; 45: 629–33.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abraham, R.B., Marouani, N. & Weinbroum, A.A. Dextromethorphan Mitigates Phantom Pain in Cancer Amputees. Ann Surg Oncol 10, 268–274 (2003). https://doi.org/10.1245/ASO.2003.08.007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2003.08.007